Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Anile

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Journal of Neurosurgical Sciences|February 12, 2020
Impact of 4K ultra-high-definition endoscope in pituitary surgery: analysis of a comparative institutional case seriesQ Giorgio D'Alessandris, Mario Rigante, Pier Paolo Mattogno, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 12, 2010
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final reportMario Balducci, Giuseppina Apicella, Stefania Manfrida, et al.
Oncotarget|July 19, 2015
The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivorsBarbara Fazi, Armando Felsani, Luigi Grassi, et al.
American Journal of Clinical Oncology|February 8, 2013
Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials?Alba Fiorentino, Mario Balducci, Pasquale De Bonis, et al.
Pituitary|July 6, 2013
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature reviewSabrina Chiloiro, Antonio Bianchi, Francesco Doglietto, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 30, 2011
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysisGiuseppe Roberto D'Agostino, Rosa Autorino, Angelo Pompucci, et al.
Neuro-Oncology|October 14, 2011
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility studyMario Balducci, Silvia Chiesa, Barbara Diletto, et al.
Endocrine|December 26, 2019
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumoursDonato Iacovazzo, Sabrina Chiloiro, Eivind Carlsen, et al.
European Journal of Endocrinology|November 21, 2015
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical studyDonato Iacovazzo, Eivind Carlsen, Francesca Lugli, et al.
Medical Oncology (Northwood, London, England)|June 8, 2012
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studiesMario Balducci, Alba Fiorentino, Pasquale De Bonis, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of Neurosurgical Sciences|February 12, 2020
Impact of 4K ultra-high-definition endoscope in pituitary surgery: analysis of a comparative institutional case seriesQ Giorgio D'Alessandris, Mario Rigante, Pier Paolo Mattogno, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 12, 2010
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final reportMario Balducci, Giuseppina Apicella, Stefania Manfrida, et al.
Oncotarget|July 19, 2015
The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivorsBarbara Fazi, Armando Felsani, Luigi Grassi, et al.
American Journal of Clinical Oncology|February 8, 2013
Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials?Alba Fiorentino, Mario Balducci, Pasquale De Bonis, et al.
Pituitary|July 6, 2013
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature reviewSabrina Chiloiro, Antonio Bianchi, Francesco Doglietto, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 30, 2011
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysisGiuseppe Roberto D'Agostino, Rosa Autorino, Angelo Pompucci, et al.
Neuro-Oncology|October 14, 2011
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility studyMario Balducci, Silvia Chiesa, Barbara Diletto, et al.
Endocrine|December 26, 2019
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumoursDonato Iacovazzo, Sabrina Chiloiro, Eivind Carlsen, et al.
European Journal of Endocrinology|November 21, 2015
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical studyDonato Iacovazzo, Eivind Carlsen, Francesca Lugli, et al.
Medical Oncology (Northwood, London, England)|June 8, 2012
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studiesMario Balducci, Alba Fiorentino, Pasquale De Bonis, et al.
Pageof 10